What’s new: China’s top health regulator plans this year to finish off revisions to guidelines on how human genetic material can be used in the country amid complaints that current restrictions are choking innovation.
In its legislative work plan for this year, the National Health Commission (NHC) included an amendment to the Detailed Rules for the Implementation of the Regulation on the Administration of Human Genetic Resources. The NHC released the work plan last week.
